Press Release

Feb. 06 2004— Norwell, MA - Diagenix Corporation today announced that it has selected Vocalocity as a preferred VoiceXML gateway provider. Diagenix plans to integrate Vocalocity's VocalOS product into it’s Teleframe Enterprise Voice Platform. The announcement comes at a time when Diagenix is moving towards using open multi-vendor solutions that are based on VoiceXML and SALT. “We looked at a number of VoiceXML Gateways and really liked what Vocalocity had to offer and the direction they were taking, said Anton Arapoff, President of Diagenix. “Integrating tools like Vocalocity's OS will enable us to focus on the voice application space rather than on telephony platform nuts and bolts, adds Arapoff.

Diagenix plans on offering its entire range of voice applications and components on standards-based platforms that support VoiceXML or SALT.  Diagenix will provide a migration path to the new technology for existing customers through an upgrade program. Diagenix is also working to certify that its voice applications and components will run on a wide range of third-party telephony platforms from vendors such as: Avaya, Intervoice, Edify, Nortel, Nuance, VoiceGenie, IBM, Syntellect, Aspect, and Genesys.

About Diagenix
Diagenix is an innovative voice application company that provides enterprise-class voice, speech, and IVR solutions that enable organizations to provide anytime, anywhere access to information and resources over the telephone and via the internet. Diagenix makes voice- and web-based services strategic tools for improving customer service, reducing costs, and improving workforce productivity. Our customers include FORTUNE 500 organizations throughout the U.S. and Canada as well as government agencies. Diagenix products and services are sold and distributed through a direct sales organization and through select business partners.

For more information about Diagenix and its products and services, please visit our website at or call us at 781-871-6624.
Contact Information
Press Contacts:
Anton Arapoff
Diagenix Corp.